CT
NVO

Caldwell Trust’s Novo Nordisk NVO Stock Holding History

Caldwell Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.09K Hold
220
– – ﹤0.01% 679
2025
Q4 		$11.2K Sell
220
-1,447
-87% -$74K ﹤0.01% 642
2025
Q3 		$92.5K Sell
1,667
-12,010
-88% -$703K 0.01% 397
2025
Q2 		$944K Sell
13,677
-2,035
-13% -$138K 0.09% 167
2025
Q1 		$1.09M Buy
15,712
+188
+1% +$15.5K 0.12% 154
2024
Q4 		$1.34M Buy
15,524
+1,289
+9% +$139K 0.14% 131
2024
Q3 		$1.69M Buy
14,235
+6,816
+92% +$909K 0.18% 116
2024
Q2 		$1.06M Buy
7,419
+4,379
+144% +$580K 0.12% 142
2024
Q1 		$390K Buy
3,040
+2,940
+2,940% +$350K 0.05% 239
2023
Q4 		$10.3K Buy
+100
New +$9.89K ﹤0.01% 604

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Caldwell Trust's NVO Position: Q1 2026 in Review

Caldwell Trust held its Novo Nordisk (NVO) position steady in Q1 2026 at 220 shares worth $8.09K. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Caldwell Trust first reported a position in NVO in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.69M in Q3 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Caldwell Trust held 220 shares of Novo Nordisk worth $8.09K as of Q1 2026.
  • Caldwell Trust left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up ﹤0.01% of Caldwell Trust's portfolio in Q1 2026, its #679 holding.
  • Caldwell Trust first reported a position in Novo Nordisk in Q4 2023 and has held it in 10 quarters since.
  • Caldwell Trust's Novo Nordisk position peaked at $1.69M in Q3 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.